Leucid Bio
Leucid is progressing novel cart therapies that produce a better and more durable response.
Leucid Bio has raised €14M across 1 funding round from 5 investors, most recently a Series A round in Oct 2021. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.leucid.com ↗
Total raised
€14M
€13,630,437
Funding rounds
1
Investors
5
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearLeucid Bio — funding by year — interactive chart.
Data table
| Leucid Bio — funding by year | |
|---|---|
| 2021 | €14M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-22 | Series A | €14M | 2Invest,Epidarex Capital,Future Fund,Sofinnova Partners,Vulpes Investment Management | View deal → |